Recombinant SARS-CoV Matrix Protein (aa 182-216) (CAT#: VReP-Wyb029)
For Research Use Only. We do not provide direct services or products for patients.
SARS-CoV, Recombinant Protein, Matrix protein (aa 182-216).
ELISA, WB, SDS-PAGE, Immunogen, etc.
Each vial contains 100 μg of lyophilized protein in 50mM Tris-HCl, 60mM NaCl and 50% glycerol.
> 95% pure by SDS-PAGE.
Store at 2 °C to 8 °C short term, -20 °C long term.
A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximately 27 to 31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.
E2; E2 glycoprotein; Peplomer protein; S; S glycoprotein; Severe acute respiratory syndrome spike glycoprotein; Severe acute respiratory syndrome virus spike glycoprotein; Spike glycoprotein; VGL2; SARS-CoV; Coronavirus (SARS assoc) Spike; Coronavirus SAR